NEOMYCIN SULFATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Neomycin Sulfate, and what generic alternatives are available?
Neomycin Sulfate is a drug marketed by Bristol Myers Squibb, Chartwell Molecular, Lannett, Lilly, Nostrum Labs Inc, Roxane, Sandoz, Teva, Xgen Pharms, Bausch And Lomb, Pharmafair, Alcon Pharms Ltd, Fougera, and Pharmaderm. and is included in twenty NDAs.
The generic ingredient in NEOMYCIN SULFATE is neomycin sulfate; triamcinolone acetonide. There are nineteen drug master file entries for this compound. Additional details are available on the neomycin sulfate; triamcinolone acetonide profile page.
Summary for NEOMYCIN SULFATE
US Patents: | 0 |
Applicants: | 14 |
NDAs: | 20 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 99 |
Clinical Trials: | 10 |
Patent Applications: | 3,993 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NEOMYCIN SULFATE at DailyMed |
Recent Clinical Trials for NEOMYCIN SULFATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Mahidol University | Phase 4 |
University of Minnesota | Early Phase 1 |
Litholink Corp | Early Phase 1 |
Pharmacology for NEOMYCIN SULFATE
Drug Class | Aminoglycoside Antibacterial |
Medical Subject Heading (MeSH) Categories for NEOMYCIN SULFATE
Anatomical Therapeutic Chemical (ATC) Classes for NEOMYCIN SULFATE
US Patents and Regulatory Information for NEOMYCIN SULFATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bristol Myers Squibb | NEOMYCIN SULFATE | neomycin sulfate | TABLET;ORAL | 060365-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Fougera | NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE | neomycin sulfate; triamcinolone acetonide | OINTMENT;TOPICAL | 062608-001 | May 23, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sandoz | NEOMYCIN SULFATE | neomycin sulfate | TABLET;ORAL | 061586-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |